R&D and Innovation
What is R&D in a CRO?
In the ever-changing world of innovative drug development, foresight is our greatest asset. At Quality Assistance, we actively prepare for tomorrow’s analytical challenges with an entire R&D and Innovation Department.
Our dedicated R&D team combines scientific management, regulatory surveillance, and analytical expertise to support the development of your innovative drug.
Our process in action: from analysis to solution
-
Strategic monitoring: the expert’s eye
It all begins with our Scientific Advisors. With deep, product-specific expertise, they monitor the evolving regulatory landscape, scientific publications and market trends. Their mission is to identify emerging analytical needs for next-generation therapies. This proactive “Fit & Gap” analysis helps us detect potential shortfalls and opportunities for innovation before they become obstacles.
-
R&D: our engine for innovation
Once a gap is identified, it becomes the starting point for our integrated R&D projects. These internal initiatives are designed to develop or enhance our analytical capabilities. We invest resources in implementing tailored GxP-ready solutions for the most complex drugs. This ongoing commitment to R&D ensures that when you approach us, the analytical solution is already in development.
-
Expertise transfer: from innovation to real-life application
The results of our research are then seamlessly transferred to our Scientific Operations teams. With GxP standards in mind, our teams integrate these technological advancements. This means you benefit from cutting-edge expertise that has been fully vetted and is ready to be applied to your project's specific requirements.
Our R&D strategy is built around a dynamic and collaborative framework. Our internal expertise connects with external stakeholders (regulatory authorities – including participation in EDQM’s working groups, industry partners and academic institutions) to ensure that every project benefits form the latest scientific insight.
This allows us to
- Anticipate and respond to regulatory changes
- Support the development of complex drug modalities
- Ensure continuity and scalability from innovation to routine analysis
Building strong partnerships
We believe that collaboration is key to scientific progress. Quality Assistance is actively engaged in strategic partnerships with industry leaders and academic institutions. Theses collaborations enable us to co-develop innovative solutions and stay at the forefront of analytical science.
Our Scientific Advisory Board
To further strengthen our scientific leadership, we have established a Scientific Advisory Board (SAB) composed of internationally recognised experts. This initiative reflects our commitment to excellence and ensures that our R&D strategy remains aligned with the latest scientific advancements and regulatory expectations.